Bertrand Le Bourdonnec, Ph.D.
About Bertrand Le Bourdonnec, Ph.D.
Bertrand Le Bourdonnec, Ph.D., serves as the Vice President of Chemistry, Pharmaceutical, and PreClinical Sciences at Deciphera Pharmaceuticals. He has over two decades of experience in the pharmaceutical industry, holding leadership roles in various companies and possessing a strong academic background in chemistry and drug design.
Work at Deciphera Pharmaceuticals
Bertrand Le Bourdonnec, Ph.D. serves as the Vice President of Chemistry, Pharmaceutical, and PreClinical Sciences at Deciphera Pharmaceuticals. He has been in this role since 2020, contributing to the company's research and development efforts in Exton, Pennsylvania. His responsibilities include overseeing various chemistry functions, which are critical for the development of new pharmaceutical products.
Previous Experience in Pharmaceutical Industry
Prior to his current position, Le Bourdonnec held several significant roles in the pharmaceutical industry. He worked at Adolor Corporation as Senior Director of Program Management & Discovery from 2000 to 2011. He also served as Vice President of Discovery Chemistry & Pharmaceutical Research at Cubist Pharmaceuticals from 2012 to 2015, and as Senior Vice President of Chemistry, Program Management, and Pharmaceutical Operations at Yumanity Therapeutics from 2015 to 2020. Throughout these roles, he managed large teams and was involved in various aspects of drug development.
Education and Expertise
Le Bourdonnec has a strong educational background in chemistry and medicinal chemistry. He earned his Ph.D. in Synthetic Organic & Medicinal Chemistry from the University of Lille 1 Sciences and Technology between 1994 and 1997. He also holds a Master's degree in Organic Chemistry from Université de Bretagne Occidentale and a Master's in Drug Design from Institut de Chimie Pharmaceutique Albert Lespagnol. Additionally, he completed a Certificate in Project Leadership from Cornell University in 2009.
Leadership and Management Skills
In his various roles, Le Bourdonnec has demonstrated strong leadership and management skills. He managed a department of approximately 90 members at Adolor Corporation and led a cross-functional product development team of around 100 members at Cubist Pharmaceuticals. His experience includes overseeing multi-million dollar budgets and conducting net present value (NPV) analysis for development and commercial assets.
Business Development and Strategic Initiatives
Le Bourdonnec has been actively involved in business development and licensing throughout his career. He has experience in mergers and acquisitions, as well as investor and media relations. His strategic initiatives have contributed to the growth and success of the organizations he has worked with, particularly in the areas of drug development and commercialization.